We hypothesized that synaptic dysfunction due to increased AD-related brain pathology (amyloid aggregation, tau) renders gray matter morphology more dissimilar at a regional level, resulting in differences between Carriers and non-Carriers. This evidence concerns the gene MAPT and Alzheimer disease.